Navigation Links
Long-term Use of Stomach Drugs may Weaken Bones

Usage of certain stomach drugs may weaken the bones in the long run and increase the risk of hip fracture, warns a new study that advises doctors to consider the risk when// prescribing such drugs.

Researchers at the University of Pennsylvania Medical School studied records from the general practice research database of Britain. All the people involved were aged over 50 and some had been taking proton pump inhibitors (PPI).

PPI's are a group of drugs whose main action is pronounced and long-lasting reduction of gastric acid production.

The research found that people who had been taking the drugs for over a year had a 44 percent greater risk of suffering a hip fracture, reported the online edition of BBC News.

Taking the drugs for even longer seemed to increase the risk further, according to the study that appeared in the Journal of the American Association.

Hip fracture is one of the most significant causes of severe disability in older people - up to one in five people who suffer a fracture following a fall die within 12 months.

Source-IANS
'"/>




Page: 1

Related medicine news :

1. Long-term use of calcium supplements to prevent colon cancer
2. Long-term Care Should Be A Planned Affair
3. Long-term Ibuprofen Therapy After Brain Injury Deteriorate Cognitive Abilities
4. Global AIDS Conference Calls for Long-term Strategies
5. Asthma Sufferers Favor Quick Relief Over Long-term Control
6. Long-term Marijuana Smoking Leads to Respiratory Complaints
7. Tamoxifen Yields Long-term Reduction in Breast Cancer Risk
8. Animal Fat Enhances Risk Of Stomach
9. Stomach infections may be associated with irregular heart rhythm
10. Proteinomics Research holds Key to Stomach Cancer
11. Can Home Remedy For Stomachache Work?
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/20/2017)... ... September 20, 2017 , ... ... Excellence (CoE) with the latest Artificial Intelligence (AI) thinking, announced today the launch ... and easy access to essential information that offers a more comprehensive understanding of ...
(Date:9/20/2017)... ... September 20, 2017 , ... Renal ... for people who have kidney disease. The theme “Describe a positive decision that ... Entrants needed to meet only one qualification— to have been diagnosed with ...
(Date:9/20/2017)... Houston, TX (PRWEB) , ... September 20, 2017 ... ... the date of the much-anticipated fall event , Look Awesome This Autumn ... demonstrations, personalized consultations, special pricing and refreshments. , Mirror Mirror Beauty Boutique ...
(Date:9/20/2017)... ... September 20, 2017 , ... As part of ... recently unveiled a redesigned website. The new site – still located at ... architects, contractors and other industry users that Garland serves. , After an ambitious ...
(Date:9/20/2017)... ... September 20, 2017 , ... In just a short time since going on ... positive feedback from customers trying the product for the first time, and others who ... developed by neurosurgeon Shawn Moore, MD, for everyone from athletes at risk from multiple ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... Eli Lilly and Company (NYSE: ... for galcanezumab and lasmiditan, two investigational treatments for migraine, ... (IHC) taking place Sept. 7-10 in Vancouver ... long-term data from an open-label study evaluating the safety ... and 240 mg) for the prevention of migraine. Galcanezumab ...
(Date:9/5/2017)... LONDON , Sept. 5, 2017  Just 18 ... Valid Insight is pleased to announce the appointment of ... Tammy Wynne , Dominic Jones-Phillips and ... from industry. ... a team of market access writers. She has over ...
(Date:9/1/2017)... Sept. 1, 2017  Bayer will present the latest research ... for Medical Oncology (ESMO) 2017 Congress, September 8-12 in ... new preclinical and clinical data on Bayer,s marketed portfolio and ... projects. "We value ... in cancer research at ESMO," said Carsten Brunn , ...
Breaking Medicine Technology: